Lyell Immunopharma Inc. – Filings and Transcripts

NASDAQ: LYEL
Share price (6/2/26): $14.89
Market cap (6/2/26): $347 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Shelf registration

Ownership Filter

ARCH Venture Fund IX, L.P.

Explore Investments LLC/DE

Euler Fund, L.P.

News Filter

Reports Business Highlights and Financial Results for the First Quarter 2026

Reports Q4 and Full Year 2025 Business and Financial Results

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness